Clinical Trial Update: Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Clinical trial comparing exenatide with insulin glargine to assess changes in liver fat content in adults with type 2 diabetes and non-alcoholic fatty liver dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)
• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Fudan University | Conditions: Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease | Phase 4 | Status: COMPLETED